Cognition Therapeutics/$CGTX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Cognition Therapeutics
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
Ticker
$CGTX
Sector
Primary listing
Employees
27
Headquarters
Website
CGTX Metrics
BasicAdvanced
$148M
-
-$0.46
-
-
Price and volume
Market cap
$148M
52-week high
$3.83
52-week low
$0.22
Average daily volume
1.7M
Financial strength
Current ratio
6.445
Quick ratio
6.197
Long term debt to equity
0.58
Total debt to equity
1.04
Interest coverage (TTM)
-3,450.08%
Profitability
EBITDA (TTM)
-44.802
Management effectiveness
Return on assets (TTM)
-78.99%
Return on equity (TTM)
-109.73%
Valuation
Price to book
4.06
Price to tangible book (TTM)
4.06
Price to free cash flow (TTM)
-3.515
Free cash flow yield (TTM)
-28.45%
Free cash flow per share (TTM)
-0.478
Growth
Earnings per share change (TTM)
-52.17%
3-year earnings per share growth (CAGR)
-25.28%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cognition Therapeutics stock?
Cognition Therapeutics (CGTX) has a market cap of $148M as of November 11, 2025.
What is the P/E ratio for Cognition Therapeutics stock?
The price to earnings (P/E) ratio for Cognition Therapeutics (CGTX) stock is 0 as of November 11, 2025.
Does Cognition Therapeutics stock pay dividends?
No, Cognition Therapeutics (CGTX) stock does not pay dividends to its shareholders as of November 11, 2025.
When is the next Cognition Therapeutics dividend payment date?
Cognition Therapeutics (CGTX) stock does not pay dividends to its shareholders.
What is the beta indicator for Cognition Therapeutics?
Cognition Therapeutics (CGTX) does not currently have a Beta indicator.